We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
BIVI icon
476
BioVie
BIVI
$12.4M
$12.4M $1.43 3.62%
KTTA icon
477
Pasithea Therapeutics
KTTA
$12.4M
$12.4M $0.3702 0.16%
ATYR icon
478
aTyr Pharma
ATYR
$12.4M
$12.4M $4.94 8.01%
CLGN icon
479
CollPlant Biotechnologies
CLGN
$11.9M
$11.9M $4.13 6.14%
LPCN icon
480
Lipocine
LPCN
$11.9M
$11.9M $1.44 5.26%
TCRX icon
481
TScan Therapeutics
TCRX
$11.8M
$11.8M $0.1745 10.5%
ICU icon
482
SeaStar Medical
ICU
$11.8M
$11.8M $2.24 3.03%
CLRB icon
483
Cellectar Biosciences
CLRB
$11.4M
$11.4M $1.21 0.82%
PASG icon
484
Passage Bio
PASG
$11.1M
$11.1M $3.45 1.99%
INTS icon
485
Intensity Therapeutics
INTS
$11.1M
$11.1M $3.40 1.8%
LSTA icon
486
Lisata Therapeutics
LSTA
$11M
$11M $1.02 0.99%
GDTC icon
487
CytoMed Therapeutics
GDTC
$11M
$11M $0.9188 2.02%
TVRD icon
488
Tvardi Therapeutics
TVRD
$10.6M
$10.6M $0.7928 8.13%
AZR
489
Azora Therapeutics, Inc. Common Stock
AZR
$10M
$10M $3.81 21.9%
PHIO icon
490
Phio Pharmaceuticals
PHIO
$10M
$10M $0.8600 0.3%
CALC icon
491
CalciMedica
CALC
$10M
$10M $1.46 16.6%
TPST icon
492
Tempest Therapeutics
TPST
$9.9M
$9.9M $0.4955 7.07%
BLRX icon
493
BioLineRX
BLRX
$9.9M
$9.9M $1.99 1.49%
LTRN icon
494
Lantern Pharma
LTRN
$9.9M
$9.9M $0.6608 9.6%
GTBP icon
495
GT Biopharma
GTBP
$9.6M
$9.6M $5.32 5%
PTN icon
496
Palatin Technologies
PTN
$8.9M
$8.9M $5 1.42%
INAB icon
497
IN8bio
INAB
$8.89M
$8.89M $0.9013 8.04%
CMMB icon
498
Chemomab Therapeutics
CMMB
$8.5M
$8.5M $1.16 6.42%
ENSC icon
499
Ensysce Biosciences
ENSC
$8.19M
$8.19M $0.4210 3.88%
CURX
500
Curanex Pharmaceuticals
CURX
$8.09M
$8.09M $5.16 4.45%
18 19
20
21 22

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.31T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $142B, Regeneron Pharmaceuticals (REGN) at $96B and Moderna (MRNA) at $88.5B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.